1.33 J&J to buy targeted cancer therapy developer Ambrx for $2 billion

<< vissza

J&J to buy targeted cancer therapy developer Ambrx for $2 billion
Dátum: 2024-01-08 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×